Drug eluting stents: risks of late restenosis sustained for up to three yearsBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39143.385012.BE (Published 08 March 2007) Cite this as: BMJ 2007;334:500
Two academic centres in the Netherlands and Switzerland have been routinely using drug eluting stents during percutaneous coronary interventions since 2002. When researchers looked at what happened to more than 8000 of their patients between 2002 and 2005, they found …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial